First Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$250K Buy
954
+8
+0.8% +$2.05K 0.19% 72
2026
Q2
$238K Sell
946
-96
-9% -$20.7K 0.17% 73
2026
Q1
$227K Sell
1,042
-35
-3% -$7.76K 0.19% 74
2025
Q4
$246K Sell
1,077
-12
-1% -$2.73K 0.21% 66
2025
Q3
$252K Sell
1,089
-64
-6% -$13K 0.22% 66
2025
Q2
$214K Buy
1,153
+6
+0.5% +$1.12K 0.21% 71
2025
Q1
$240K Buy
+1,147
New +$223K 0.27% 55

Other funds holding ABBV

First Financial Group's ABBV Position: Q3 2026 in Review

First Financial Group increased its AbbVie (ABBV) stake by 0.85% in Q3 2026, buying an estimated $2.05K and bringing the position to 954 shares worth $250K. The position accounts for 0.19% of the portfolio, ranked #72.

First Financial Group first reported a position in ABBV in Q1 2025 and has held it in 7 quarters since. The position peaked at $252K in Q3 2025. 2,083 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • First Financial Group held 954 shares of AbbVie worth $250K as of Q3 2026.
  • First Financial Group bought 8 AbbVie shares in Q3 2026, an estimated $2.05K.
  • AbbVie made up 0.19% of First Financial Group's portfolio in Q3 2026, its #72 holding.
  • First Financial Group first reported a position in AbbVie in Q1 2025 and has held it in 7 quarters since.
  • First Financial Group's AbbVie position peaked at $252K in Q3 2025.
  • 2,083 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on First Financial Group's 13F filing for Q3 2026, filed 22 Oct 2026.